Mithra Pharmaceuticals SA (OTCMKTS:MITPF) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 191,500 shares, a growth of 36.4% from the March 15th total of 140,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,915.0 days.
Separately, ING Group initiated coverage on Mithra Pharmaceuticals in a research note on Tuesday, March 30th. They issued a “buy” rating for the company.
OTCMKTS MITPF remained flat at $$23.90 on Friday. Mithra Pharmaceuticals has a one year low of $18.32 and a one year high of $24.75.
Further Reading: Buy-Side Analysts
Receive News & Ratings for Mithra Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mithra Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.